TNFSF10 and Miyoshi myopathy: Taken together, we report that sublethal doses of α-TOS selectively enhance TRAIL-dependent apoptotic signalling in MM via mitochondrial pathways, while antagonising the activity of TRAIL in nonmalignant mesothelial cells.